Oragenics (NYSEAMERICAN:OGEN) Stock Jumps 0.1% – What’s Next?

Oragenics, Inc. (NYSEAMERICAN:OGEN)’s stock price rose 0.1% during trading on Friday. The stock traded as high as $0.3506 and last traded at $0.3492. 8,868 shares changed hands during trading, a decline of 59% from the average daily volume of 21,886 shares. The stock had previously closed at $0.3490.

Oragenics Trading Up 0.1%

The firm has a 50-day moving average of $0.46 and a 200-day moving average of $0.60. The stock has a market capitalization of $1.57 million, a price-to-earnings ratio of -0.02 and a beta of 1.28.

Oragenics (NYSEAMERICAN:OGEN) last issued its earnings results on Thursday, August 13th. The company reported ($0.57) earnings per share (EPS) for the quarter.

About Oragenics

Oragenics, Inc is a biotechnology company focused on developing intranasal medicines for neurological disorders. Its approach is designed to deliver drug candidates through the nasal passage directly to the brain, with the goal of addressing conditions for which conventional drug-delivery methods may be limited.

The company’s lead product candidate is ONP-002, an intranasal therapy being developed for the treatment of concussion and traumatic brain injury. Oragenics has also pursued additional preclinical programs targeting neurological and neurodegenerative diseases, although the development status and scope of these programs may change as the company advances its pipeline.

Founded in 1996 and headquartered in Florida, Oragenics historically worked on oral-care and antibiotic technologies, including products based on lantibiotics and beneficial bacteria.